Placenta is a rich reservoir of stem and progenitor cells, bioactive molecules, and extracellular matrix (ECM) with great potential in regenerative medicine and tissue engineering. These active biologics have a wide spectrum of immunomodulatory properties that help promote tissue regeneration. The scientific evidence supports their use in regenerative medicine. Mesenchymal stem cells (MSCs) have been isolated from several placental regions. Various studies have reported that placental derived MSCs have improved proliferative capacity, life span, and differentiation potential compared to bone marrow-MSCs. The chorionic villi (CV) of human term placenta are a rich source of MSCs. CV-MSCs resemble embryonic stem cells due to the early development stage of placenta. Placenta produce many bioactive molecules which can mediate various biological effects including anti-inflammatory responses, reepithelialization, angiogenic properties. In addition to the bioactive molecules identified in whole placental tissues, there are several bioactive molecules specifically derived from MSCs collectively called MSC-derived secretome. This secretome is defined as the set of MSC-derived bioactive molecules secreted to the extracellular space. Recent reports suggest that the therapeutic activity of MSCs is mainly mediated by the paracrine effect of their secretomes. The ECM is another biologically active component in placenta with an important role in regenerative medicine. ECMs are widely used to augment wound healing and tissue repair for a variety of injuries in both surgical and nonsurgical applications. In addition to providing a substrate for tissue reconstruction, many ECM scaffolds can sequester and release growth factors that can promote tissue regeneration through modulation of the immune response, and the recruitment and stimulation of stem/progenitor cells and fibroblasts. Complete Medical uses a connective tissue allograft comprising a combination of cryopreserved amniotic fluid, amnion/chorion membrane, and umbilical cord tissue, including Wharton’s jelly. The immunomodulatory and anti-inflammatory effects of these biologics, plus their promotion of tissue regeneration make the use in regenerative medicine highly effective and safe. An increasing body of evidence has shown that placental tissues have clinical benefits in a wide range of wound repair and surgical applications and Regenerative medicine.
Regenerative Cell Therapy Success
Regenerative Cell Therapy is an interdisciplinary field of research and clinical applications focused on the repair, replacement, and/or regeneration of cells, tissues and organs to restore impaired function resulting from congenital defects, disease, trauma and ageing. It uses a combination of several existing and newly emerging technological approaches that moves it beyond traditional transplantation and replacement therapies. These approaches include the use of active biologics such as stem and progenitor cell therapy. Stem and progenitor cells are currently being evaluated for the therapy of multiple diseases such as leukemia, lymphoma, brain and spinal cord injury, heart failure, hearing loss, blindness and vision impairment, teeth missing, and other degenerative diseases. Regenerative medicine has been recognized worldwide as a developing research field that offers the potential to revolutionize patient care in the 21st century. The prospect of addressing massive healthcare markets, such as cardiovascular disease, neurological conditions, cancer or chronic metabolic diseases has raised significant interest in this field.
MSCs Stem Cells
Mesenchymal Stem Cells- MSCs Around the world, scientists are evaluating stable, safe and highly accessible MSCs sources with great potential for regenerative medicine. Placenta represents a remarkable source of MSCs, either isolated from the chorionic villi or from the amniotic membranes.
Definition of MSCs
MSCs are non-hematopoietic adult stem cells, which can be isolated
from various mammalian tissue sources. They are self-renewable, multipotent, and capable of
being expanded in vitro and possess exceptional genomic stability. Human MSCs are multipotent
with the capacity to differentiate into mesodermal (osteocytes, adipocytes and chondrocytes),
ectodermal (neurocytes), and endodermal (hepatocytes) lineages osteoblasts.
Complete Medical Uses only the most affective available Stem Cells for optimal success.
The connective tissue allograft comprising a combination of cryopreserved amniotic fluid, amnion/chorion membrane, and umbilical cord tissue, including Wharton’s jelly. This product is meticulously harvested from perinatal tissue of healthy human c-section births and minimally manipulated through a proprietary process, which maintains the functions of placental tissue containing significant amounts of MSCs and progenitor cells, ECM, growth factors, and cytokines. The immunomodulatory and anti-inflammatory effects of these active biologics, plus their tissue regenerative attributes, make their use in regenerative medicine highly effective and safe
Join the Complete medical patients that have received amazing results through this life changing regenerative therapy that works!
Disclaimer
The use of stem cell treatments are not FDA approved. Even though these treatments are investigational, highly promising and significant results have been documented. As with all treatments, results meeting your expectations cannot be guaranteed. By offering Placenta Derived Stem Cells, Complete Medical Weight Loss and Anti-Aging does not claim to cure any condition, disease or injury. No statements or implied treatments on this website have been evaluated or approved by the FDA. This website contains no medical advice. All statements and opinions provided by this website are provided for educational and informational purposes only and we do not diagnose or treat via this website or via telephone.